[Federal Register: July 28, 1999 (Volume 64, Number 144)] [Notices] [Page 40874] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr28jy99-81] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability and Injury Prevention and Control Special Emphasis Panel: Nutritional Biochemistry Cooperative Agreements for Innovative Technology Development Grant for Detection and Monitoring of Diabetic Hypoglycemia by Non- or Minimally-Invasive Techniques In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting. Name: Disease, Disability and Injury Prevention and Control Special Emphasis Panel: Nutritional Biochemistry Cooperative Agreements for Innovative Technology Development Grant for Detection and Monitoring of Diabetic Hypoglycemia by Non-or Minimally-Invasive Techniques, Program Announcement #99151. Times and Dates: 8:30 a.m.-9 a.m., August 12, 1999 (Open); 9 a.m.-5 p.m., August 12, 1999 (Closed); 9 a.m.-4 p.m., August 13, 1999 (Closed). Place: Atlanta Marriott North Central, 2000 Century Boulevard NE, Atlanta, Ga. 30345-3377. Telephone 404/325-0000. Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Associate Director for Management and Operations, CDC, pursuant to Public Law 92-463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement #99151. Contact Person for More Information: Dayton T. Miller, Ph.D., Chief, Nutritional Biochemistry Branch, NCEH, CDC, 4770 Buford Hwy., m/s F18, Atlanta, Ga. 30341-3724. Telephone 770/488-4579, e-mail dtm1@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for the both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: July 22, 1999. Carolyn J. Russell, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 99-19235 Filed 7-27-99; 8:45 am] BILLING CODE 4163-18-P